Three members of a U.S. Food and Drug Administration advisory committee have resigned after the agency this week approved a new drug for Alzheimer disease…
Affecting over 50 million people, Alzheimer’s disease is the most common form of dementia and primarily occurs in people over the age of 65. The…
Much like a supply truck crossing the countryside, the misfolded proteins that damage neurons in Alzheimer’s disease travel the “roads” of the brain, sometimes stopping…
Researchers remain perplexed as to what causes dementia and how to treat and reverse the cognitive decline seen in patients. In a first-of-its-kind study, researchers…
A new Cleveland Clinic-led study has identified mechanisms by which COVID-19 can lead to Alzheimer’s disease-like dementia. The findings, published in Alzheimer’s Research & Therapy,…
Increasing evidence shows that physical activity and exercise training may delay or prevent the onset of Alzheimer’s disease (AD). In aging humans, aerobic exercise training…
A team of researchers associated with several institutions in the U.K., Germany and the U.S. has found evidence of an unusual kind of copper and…
Earlier this week, the federal Food and Drug Administration (FDA) approved the use of the drug aducanumab to treat Alzheimer’s disease—making it the first new…
Dr. Katya Numbers from the Centre for Healthy Brain Ageing (CHeBA) discusses how the COVID-19 pandemic has posed unique risks to people with Alzheimer’s disease…
Alzheimer’s disease is one of medicine’s most elusive thieves, a disease that slowly and irreversibly robs a person’s ability to think, reason, remember and maintain…